BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an uncommon but important cause of sudden cardiac death. OBJECTIVES: This study sought to develop an artificial intelligence approach for the detection of HCM based on 12-lead electrocardiography (ECG). METHODS: A convolutional neural network (CNN) was trained and validated using digital 12-lead ECG from 2,448 patients with a verified HCM diagnosis and 51,153 non-HCM age- and sex-matched control subjects. The ability of the CNN to detect HCM was then tested on a different dataset of 612 HCM and 12,788 control subjects. RESULTS: In the combined datasets, mean age was 54.8 ± 15.9 years for the HCM group and 57.5 ± 15.5 years for the control group. After training and validation, the area under the curve (AUC) of the CNN in the validation dataset was 0.95 (95% confidence interval [CI]: 0.94 to 0.97) at the optimal probability threshold of 11% for having HCM. When applying this probability threshold to the testing dataset, the CNN's AUC was 0.96 (95% CI: 0.95 to 0.96) with sensitivity 87% and specificity 90%. In subgroup analyses, the AUC was 0.95 (95% CI: 0.94 to 0.97) among patients with left ventricular hypertrophy by ECG criteria and 0.95 (95% CI: 0.90 to 1.00) among patients with a normal ECG. The model performed particularly well in younger patients (sensitivity 95%, specificity 92%). In patients with HCM with and without sarcomeric mutations, the model-derived median probabilities for having HCM were 97% and 96%, respectively. CONCLUSIONS: ECG-based detection of HCM by an artificial intelligence algorithm can be achieved with high diagnostic performance, particularly in younger patients. This model requires further refinement and external validation, but it may hold promise for HCM screening.
BACKGROUND:Hypertrophic cardiomyopathy (HCM) is an uncommon but important cause of sudden cardiac death. OBJECTIVES: This study sought to develop an artificial intelligence approach for the detection of HCM based on 12-lead electrocardiography (ECG). METHODS: A convolutional neural network (CNN) was trained and validated using digital 12-lead ECG from 2,448 patients with a verified HCM diagnosis and 51,153 non-HCM age- and sex-matched control subjects. The ability of the CNN to detect HCM was then tested on a different dataset of 612 HCM and 12,788 control subjects. RESULTS: In the combined datasets, mean age was 54.8 ± 15.9 years for the HCM group and 57.5 ± 15.5 years for the control group. After training and validation, the area under the curve (AUC) of the CNN in the validation dataset was 0.95 (95% confidence interval [CI]: 0.94 to 0.97) at the optimal probability threshold of 11% for having HCM. When applying this probability threshold to the testing dataset, the CNN's AUC was 0.96 (95% CI: 0.95 to 0.96) with sensitivity 87% and specificity 90%. In subgroup analyses, the AUC was 0.95 (95% CI: 0.94 to 0.97) among patients with left ventricular hypertrophy by ECG criteria and 0.95 (95% CI: 0.90 to 1.00) among patients with a normal ECG. The model performed particularly well in younger patients (sensitivity 95%, specificity 92%). In patients with HCM with and without sarcomeric mutations, the model-derived median probabilities for having HCM were 97% and 96%, respectively. CONCLUSIONS: ECG-based detection of HCM by an artificial intelligence algorithm can be achieved with high diagnostic performance, particularly in younger patients. This model requires further refinement and external validation, but it may hold promise for HCM screening.
Authors: Albert K Feeny; Mina K Chung; Anant Madabhushi; Zachi I Attia; Maja Cikes; Marjan Firouznia; Paul A Friedman; Matthew M Kalscheur; Suraj Kapa; Sanjiv M Narayan; Peter A Noseworthy; Rod S Passman; Marco V Perez; Nicholas S Peters; Jonathan P Piccini; Khaldoun G Tarakji; Suma A Thomas; Natalia A Trayanova; Mintu P Turakhia; Paul J Wang Journal: Circ Arrhythm Electrophysiol Date: 2020-07-06
Authors: Inas A Yassine; Ahmed M Ghanem; Nader S Metwalli; Ahmed Hamimi; Ronald Ouwerkerk; Jatin R Matta; Michael A Solomon; Jason M Elinoff; Ahmed M Gharib; Khaled Z Abd-Elmoniem Journal: Comput Biol Med Date: 2021-11-18 Impact factor: 4.589
Authors: Kasra Nezamabadi; Jacob Mayfield; Pengyuan Li; Gabriela V Greenland; Sebastian Rodriguez; Bahadir Simsek; Parvin Mousavi; Hagit Shatkay; M Roselle Abraham Journal: J Am Med Inform Assoc Date: 2022-10-07 Impact factor: 7.942
Authors: Arjan Sammani; Rutger R van de Leur; Michiel T H M Henkens; Mathias Meine; Peter Loh; Rutger J Hassink; Daniel L Oberski; Stephane R B Heymans; Pieter A Doevendans; Folkert W Asselbergs; Anneline S J M Te Riele; René van Es Journal: Europace Date: 2022-10-13 Impact factor: 5.486
Authors: George Koulaouzidis; Tomasz Jadczyk; Dimitris K Iakovidis; Anastasios Koulaouzidis; Marc Bisnaire; Dafni Charisopoulou Journal: J Clin Med Date: 2022-07-05 Impact factor: 4.964
Authors: Demilade A Adedinsewo; Amy W Pollak; Sabrina D Phillips; Taryn L Smith; Anna Svatikova; Sharonne N Hayes; Sharon L Mulvagh; Colleen Norris; Veronique L Roger; Peter A Noseworthy; Xiaoxi Yao; Rickey E Carter Journal: Circ Res Date: 2022-02-17 Impact factor: 23.213
Authors: Yuka Otaki; Ananya Singh; Paul Kavanagh; Robert J H Miller; Tejas Parekh; Balaji K Tamarappoo; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Sebastien Cadet; Joanna X Liang; Damini Dey; Daniel S Berman; Piotr J Slomka Journal: JACC Cardiovasc Imaging Date: 2021-07-14